TILT Holdings (TLLTF) Operating Margin (2021 - 2025)
TILT Holdings (TLLTF) reported Operating Margin of 47.75% for Q2 2025, down 1642.0% on a YoY basis from 3.1% in Q2 2024, and down 65.19% quarter-over-quarter from 28.91% in Q1 2025.
TILT Holdings (TLLTF) Operating Margin (2021 - 2025) Analysis & Trends
TILT Holdings has reported Operating Margin for 5 years, with the latest figure at 47.75% in Q2 2025.
- For the quarter ending Q2 2025, Operating Margin fell 1642.0% year-over-year to 47.75%; the trailing twelve-month figure through Jun 2025 stood at 61.5% (down 3775.0% YoY), and the FY2024 full-year result was 60.05%, down 3405.0% from the prior year.
- Operating Margin for Q2 2025 stood at 47.75%, down from 28.91% in the prior quarter.
- The five-year high for Operating Margin was 3.16% in Q2 2021, with the low at 143.83% in Q4 2022.
- Historically, Operating Margin has averaged 39.45% across 5 years, with a median of 28.85% in 2022.
- Annual changes were most pronounced in 2023 — Operating Margin jumped 9893 bps — and 2024, when it sank 8971 bps.
- TILT Holdings' Operating Margin stood at 63.71% in 2021, then plunged by 126 bps to 143.83% in 2022, then soared by 69 bps to 44.9% in 2023, then sank by 200 bps to 134.61% in 2024, then soared by 65 bps to 47.75% in 2025.
- The last three Operating Margin figures came in at 47.75% (Q2 2025), 28.91% (Q1 2025), and 134.61% (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | TILT Holdings | - | - | 1.82 Mn | -47.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -47.75% |
| Mar 31, 2025 | -28.91% |
| Dec 31, 2024 | -134.61% |
| Sep 30, 2024 | -27.72% |
| Jun 30, 2024 | -31.33% |
| Mar 31, 2024 | -14.37% |
| Dec 31, 2023 | -44.90% |
| Sep 30, 2023 | -10.60% |
| Jun 30, 2023 | -33.54% |
| Mar 31, 2023 | -18.03% |
| Dec 31, 2022 | -143.83% |
| Sep 30, 2022 | -15.06% |
| Jun 30, 2022 | -28.85% |
| Mar 31, 2022 | -17.67% |
| Dec 31, 2021 | -63.71% |
| Sep 30, 2021 | -6.55% |
| Jun 30, 2021 | -3.16% |